Resource Center

Oct 1, 2020
  |  Blog

October 2020 News/Events

 

Congratulations!

ISOP International society of Pharmacometrics Kevin Dykstra board of directors

 

GET TO KNOW KEVIN


Featured Video:

What’s New in MonolixSuite 2020

monolix suite 2020

MORE ABOUT MONOLIX SUITE


Featured “How-To” Videos:

GastroPlus 9.7 tutorial

 

LEARN MORE ABOUT MAXIME


gastroplus DILIsym and ADMET Predictor

NEW SOFTWARE RELEASE #WebinarWednesday

Oct. 14 – Explore new features in DSX™ with Brett Howell & Corey Berry
Register for webinar

Oct. 21 – Modeling more than just the gut with GastroPlus® v9.8 – Dan O’Connor and Neil Miller
Register for webinar

Webinars Available On-Demand:
ADMET Predictor® – What’s New in APX™
MonolixSuite: What’s new in 2020?


All major regulatory agencies, including the FDA, EMA, PMDA, ANVISA, & NMPA have licenses to GastroPlus®, with reviewers in all agencies trained on the programHindsight is 2020 & We’re Forecasting Future Pathways

All major regulatory agencies, including the FDA, EMA, PMDA, ANVISA, & NMPA have licenses to GastroPlus®, with reviewers in all agencies trained on the program.

Solving the global COVID-19 pandemic will require innovative & integrative new approaches to accelerate drug development.

Find Out How the Global Regulatory Strategies Team Can Help You!


top news reads simulation plus

 Dive Into Our Division’s Top Reads

Cognigen: Population Pharmacokinetic and Pharmacokinetic / Pharmacodynamic Modeling of Weight‐Based Intravenous Reslizumab Dosing

DSS: QST Applications, Use of Data and Species Differences

Monolix: Case study: Implementing a proportional hazard model and calculating hazard ratios

SLP: Prediction of fasted and fed bioequivalence for immediate release drug products using physiologically based biopharmaceutics modeling (PBBM)

Read More

 


virtual events

Can’t Miss Calendar Events
Oct. 8 – The UofA Faculty of Pharmacy & Pharm. Sci presents Phytocannabinoids DDIs and more!
Register for webinar

Oct. 8 – Exploring safety issues in antimicrobial drug development
Register for webinar

Oct. 9 – 2020 GMP Virtual Symposium
Register for webinar
Posters:
Quantitative Systems Toxicology (DILIsym) Modeling of the Acetaminophen (Paracetamol) Mode of Action (MOA) Pathway for Hepatotoxicity Supports that Acetaminophen Is Not a Carcinogenic Hazard in Humans

Quantitative Systems Toxicology Modeling Using DILIsym Suggests That Drug-Induced Liver Injury Can Be Enhanced by Co-administered Drugs and Mitigated by Mitochondrial Biogenesis


resource center
Copyright © 2021 Simulations Plus, All rights reserved.
Simulations Plus Monthly News & Events

Simulations Plus, Inc.:
42505 10th Street West
Lancaster, CA 93534
Telephone: +1-661-723-7723

Cognigen Corporation, a Simulations Plus company:
1780 Wehrle Drive, Suite 110
Buffalo, NY 14221-7000
Telephone: +1-716-633-3463

DILIsym Services, a Simulations Plus company:
Six Davis Drive
PO Box 12317
Research Triangle Park, NC 27709
Telephone: +1-919-558-1323

Lixoft, a Simulations Plus company
8 rue de la Renaissance Batiment D
92160 Antony, France
Telephone: +33 9 72 53 91 80

Contact Us About This Blog